Company news

Vivos Therapeutics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Vivos Therapeutics Schedules Second Quarter 2022 Financial Results Conference Call

August 8, 2022

Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for Its Entire Line of Oral Appliances

July 13, 2022

Vivos Therapeutics Announces Exclusive Distribution Agreement with GM Instruments, Ltd. for the U.S. and Canada

June 28, 2022

Vivos Therapeutics’ SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep Apnea

June 13, 2022

Vivos Therapeutics to Present at Upcoming SLEEP 2022 Annual Meeting

May 25, 2022

Vivos Therapeutics Reports First Quarter 2022 Financial Results and Operational Update

May 15, 2022

Vivos Therapeutics Schedules First Quarter 2022 Financial Results Conference Call

April 27, 2022

Vivos Therapeutics Opens Third U.S. Multidisciplinary Center to Treat Patients Suffering from Sleep Apnea with The Vivos Method

April 25, 2022

Vivos Therapeutics Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call

March 30, 2022

Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update

March 30, 2022

Vivos Therapeutics Rebrands Proprietary Clinical Protocol for Treating Patients with Breathing and Sleep Disorders

March 2, 2022

Vivos Therapeutics to Present at March 2022 World Sleep Congress in Rome

February 23, 2022

Vivos Therapeutics Files for US Patent on Proprietary New Clinical Protocols After Seeing Further Significant Improvement in Reduction of Key Sleep Apnea Metric

January 26, 2022

Vivos Therapeutics Announces 18X Increase in Sleep Apnea Diagnostic Testing By Vivos Dentists Using SleepImage Technology

January 18, 2022

Vivos Therapeutics Announces Registration with Health Canada to Manufacture and Sell Sleep Disorder, Snoring and Sleep Apnea Appliances to Canadian Dentists

December 8, 2021

Vivos Therapeutics Reports Third Quarter 2021 Financial Results and Operational Update

November 14, 2021

Vivos Therapeutics Schedules Third Quarter 2021 Financial Results Conference Call

November 8, 2021

Vivos Therapeutics Announces 2021 Annual Breathing Wellness Conference Presented by The Vivos Institute

October 18, 2021

Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A Comprehensive Sleep Apnea and Orthodontic Treatment Solution

October 17, 2021

Vivos Therapeutics Announces Formation of New Medical Consortium to Advance the Company’s Technology for Obstructive Sleep Apnea

September 22, 2021

Vivos Therapeutics and Empower Sleep Launch Cooperative Relationship Aimed at Significantly Improving Proper Obstructive Sleep Apnea Diagnosis and Treatment

August 25, 2021

FDA Grants 510(k) Market Clearance to Vivos Therapeutics’ mmRNA Oral Appliance for Treating Mild to Moderate Sleep Apnea

August 22, 2021

Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update

August 11, 2021

Vivos Therapeutics Schedules Second Quarter 2021 Financial Results Conference Call

August 8, 2021

Vivos Therapeutics Opens State of the Art International Training Center In Denver

July 28, 2021

Vivos Therapeutics Reports First Quarter 2021 Financial Results and Operational Update

May 16, 2021

Vivos Therapeutics Schedules First Quarter 2021 Financial Results Conference Call

May 12, 2021

Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

May 10, 2021

Vivos Therapeutics Announces Pricing of $24 Million Follow-On Offering

May 5, 2021

Vivos Therapeutics Announces Integrative Cardiologist Dr. Mimi Guarneri as New Medical Director of Clinical Education

April 13, 2021

Vivos Therapeutics to Launch MyoCorrect Orofacial Myofunctional Therapy Service

March 29, 2021

Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update

March 24, 2021

Vivos Therapeutics Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for Thursday, March 25, 2021 at 5: 00 pm ET

March 17, 2021

Vivos Therapeutics Announces the Opening of the First Pneusomnia Integrated Medical-Dental Sleep Center

March 7, 2021

Vivos Therapeutics Launches VivoScore Diagnostic Technology for Home Sleep Apnea Testing in Children and Adults

February 15, 2021

Vivos Therapeutics Submits FDA 510(k) Application for the Vivos mmRNA Oral Appliance

February 1, 2021

Vivos Therapeutics Forms Clinical Advisory Board to Drive Further Growth of Next-Generation Obstructive Sleep Apnea Treatment Efforts

January 28, 2021

Vivos Therapeutics Launches AireO2 Patient Management Technology to Treat Patients with Obstructive Sleep Apnea

January 5, 2021

Vivos Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

December 14, 2020

Vivos Therapeutics Announces Pricing of $21M Initial Public Offering

December 9, 2020

← Newer news releases

Calls

The 5 newest of 21 calls. Every call is listed under its year.